Stryker Corporation (SYK) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.

Total Assets Chart for Stryker Corporation

Stryker Corporation (SYK) total assets for FY2025 were USD 47.8B, a 11.3% change from FY2024. Stryker Corporation's total assets grew from USD 70.7M in 1985 to USD 47.8B in 2025 (67571.9% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 6.9%, 10-year CAGR of 11.4%, 20-year CAGR of 12.0%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$129.43B
Implied Share Price
$337.43
Enterprise Value
$140.74B
Revenue (TTM)
$25.84B
EBITDA
$7.38B
Profit Margin
14.43%
Trailing P/E
34.97
Forward P/E
22.37
Price/Book (MRQ)
5.37
Price/Sales (TTM)
5.01
EV/EBITDA
20.14
EV/Revenue
5.43
Dividend Yield
1.03%
Book Value
$59.94
Free Cash Flow (FY2025)
$4.28B
Free Cash Flow Yield
3.31%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.